AAM
LEGN icon

Advisors Asset Management’s Legend Biotech LEGN Stock Holding History

Advisors Asset Management’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-18,915
Closed -$342K – 1455
2026
Q1 		$342K Sell
18,915
-1,988
-10% -$37.9K 0.01% 1047
2025
Q4 		$454K Sell
20,903
-2,279
-10% -$65.3K 0.01% 981
2025
Q3 		$756K Sell
23,182
-538
-2% -$19.9K 0.01% 872
2025
Q2 		$842K Buy
23,720
+3,895
+20% +$126K 0.02% 817
2025
Q1 		$673K Buy
19,825
+13,070
+193% +$469K 0.01% 860
2024
Q4 		$220K Sell
6,755
-57
-0.8% -$2.36K ﹤0.01% 1103
2024
Q3 		$332K Buy
6,812
+837
+14% +$44.6K 0.01% 1018
2024
Q2 		$265K Buy
5,975
+1,481
+33% +$68.3K 0.01% 1044
2024
Q1 		$252K Buy
4,494
+1,995
+80% +$120K ﹤0.01% 1089
2023
Q4 		$150K Buy
2,499
+124
+5% +$7.86K ﹤0.01% 1157
2023
Q3 		$160K Buy
2,375
+1,606
+209% +$112K ﹤0.01% 1140
2023
Q2 		$53.1K Buy
+769
New +$50.2K ﹤0.01% 1272

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Advisors Asset Management's LEGN Position: Q2 2026 in Review

Advisors Asset Management sold out of Legend Biotech (LEGN) in Q2 2026, closing a stake of 18,915 shares — an estimated $342K sold.

Advisors Asset Management first reported a position in LEGN in Q2 2023 and held it in 12 quarters. The position peaked at $842K in Q2 2025. 218 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

  • Advisors Asset Management reported no remaining Legend Biotech position as of Q2 2026 after selling out during the quarter.
  • Advisors Asset Management sold 18,915 Legend Biotech shares in Q2 2026, an estimated $342K.
  • Advisors Asset Management first reported a position in Legend Biotech in Q2 2023 and held it in 12 quarters.
  • Advisors Asset Management's Legend Biotech position peaked at $842K in Q2 2025.
  • 218 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on Advisors Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.